KyrollisAttallaMD

Urology • New York, NY

Urologic Oncologist, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Attalla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Attalla's full profile

Already have an account?

Office
10 Union Square East, Suite 3A
New York, NY 10003

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2019 - 2021
Icahn School of Medicine at Mount SinaiResidency, Urology, 2015 - 2019
Icahn School of Medicine at Mount Sinai (Beth Israel)Internship, Surgery, 2014 - 2015
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2014
Sophie Davis School of Biomedical EducationBachelor of Science

Certifications & Licensure

NY State Medical License 2018 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

T32 Ruth L. Kirschstein Institutional National Research Service Award Memorial Sloan Kettering Cancer Center

Publications & Presentations

PubMed

The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysis.
Reuben Ben-David, Sarah Lidagoster, Jack Geduldig, Kaushik P Kolanukuduru, Yuval Elkun
Urologic Oncology. 2025-01-01
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes.
Reuben Ben-David, Sarah Lidagoster, Jack Geduldig, Kaushik P Kolanukuduru, Yuval Elkun
BJU International. 2024-10-16
9 citations
Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy.
Reuben Ben-David, Neeraja Tillu, Shivaram Cumarasamy, Parissa Alerasool, Jordan M Rich
European Urology Oncology. 2024-10-01

Journal Articles

Open Partial Nephrectomy: One Night Length of Stay Is Safe and Cost Effective
Sirohi M, Attalla K, Nagler HM, Goluboff ET, Open Journal of Urology, 9/1/2016

Books/Book Chapters

Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine
Chapter: Prostate Disease and Cancer
Kyrollis Attalla (Contributing Question Author)American Geriatrics Society; 2019, New YorkEdition 10,
Genitourinary Cancers
Chapter: Current Role of Checkpoint Inhibitors in Urologic Cancers
Page 241 - 258Kyrollis Attalla, John P. Sfakianos, Matthew D. GalskyEditors: Siamak Daneshmand, Kevin Chan.Springer2018

Abstracts/Posters

Prevalence and landscape of actionable genomic alterations in renal cell carcinoma
Attalla K, DiNatale RG, Reznik E, Fong C, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Russo P, Chan TA, Motzer RJ, Schultz ND, Voss MH, Hakimi AA, ASCO GU, podium presentation, San Francisco, 2/15/2020
The spinal distribution of metastatic renal cell carcinoma: support for locoregional rather than arterial hematogenous mode of early bony dissemination
Attalla K, Duzgol C, McLaughlin L, Flynn J, Ostrovnaya I, DiNatale RG, Silagy AW, Coleman J, Lee CH, Carlo MI, Voss MH, Russo P, Bilsky M, Hakimi AA, Moss N, ASCO GU, poster session, San Francisco, CA, 2/15/2020
Who does not receive a cytoreductive nephrectomy among IMDC intermediate-poor risk patients?
Iosepovici S, Silagy A, Mano R, Attalla K, DiNatale R, Marcon J, Motzer RJ, Coleman JA, Russo P, Hakimi AA, Society of Urologic Oncology Annual Meeting, poster session, Washington, DC, 12/5/2019
Safety and feasibility of surgery following preoperative immunotherapy in patients with metastatic renal cell carcinoma
Attalla K, DiNatale RG, Silagy AW, Marcon J, Weng S, Chen Y, Reznik E, Dalbagni G, Coleman JA, Lee CH, Carlo M, Voss M, Motzer RJ, Russo P, Hakimi AA, 18th International Kidney Cancer Symposium, poster session, Miami, Florida, 11/15/2019
Nuances in surgical selection for cytoreductive nephrectomy among IMDC intermediate-poor risk patients
Silagy AW, Iosepovici S, Mano R, Attalla K, DiNatale RG, Marcon J, Motzer RJ, Coleman JA, Russo P, Hakimi AA, 18th International Kidney Cancer Symposium, poster session, Miami, Florida, 11/15/2019
Is anesthesia associated with oncological outcomes after nephrectomy?
Silagy AW, Hannum ML, Mano R, Attalla K, DiNatale RG, Marcon J, Tan KS, Coleman JA, Russo P, Fischer GW, McCormick PJ, Hakimi AA, Mincer JS, 18th International Kidney Cancer Symposium, poster session, Miami, Florida, 11/15/2019
Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with outcome and differs between molecular subgroups
Marcon J, Di Natale RG, Weng S, Ghanaat M, Silagy AW, Mano R, Blum KA, Attalla K, Reznik E, Carlo MI, Motzer RJ, Coleman JA, Russo P, Hakimi AA, Chen YB, 18th International Kidney Cancer Symposium, poster session, Miami, Florida, 11/15/2019
Bladder Cancer Patients Without Pathologic Response to Neoadjuvant Chemotherapy Experience Lower Survival Rates Than Radical Cystectomy Alone
Pfail J, Audenet F, Martini F, Attalla K, Waingankar N, Galsky MD, Sfakianos JP, American Urological Association Annual Meeting, Chicago, Illinois, 5/4/2019
Prospective Implementation of a Non-Opioid Protocol (NOP) for Patients Undergoing Robotic-Assisted Radical Cystectomy
Attalla K, Audenet F, Giordano M, Pfail J, Lubin MA, Waingankar N, Gainsburg D, Badani KK, Sim A, Sfakianos JP, American Urological Association Annual Meeting, Chicago, Illinois, 5/3/2019
Reevaluating Warm Ischemia Time As a Predictor of Renal Function After Robotic Partial Nephrectomy
Rosen DC, Beksac AT, Attalla K, Abaza R, Eun DD, Bhandari A, Hemal AK, Porter J, Badani KK, American Urological Association Annual Meeting, San Francisco, California, 5/18/2018
Demographic and Socioeconomic Predictors of Treatment Delays, Pathologic Stage and Survival Among Patients with Penile Cancer: a Report from the National Cancer Database
Attalla K, Paulucci DJ, Blum K, Anastos H, Moses KA, Badani KK, Spiess PE, Sfakianos JP, Society of Urologic Oncology Annual Meeting, Washington DC, 11/29/2017
Prolonged Hormonal Therapy and External Beam Radiation Independently Increase the Risk of Persistent Hypogonadism in Men Treated with Prostate Brachytherapy
Sagalovich D, Attalla K, Paulucci DJ, Tewari A, Sfakianos J, Badani KK, Stock R, Stone N, American Urological Association Annual Meeting, Boston, Massachusetts, 5/12/2017
Heterogeneous Outcomes in Gleason Score 7 Prostate Cancer Patients are Associated with Differential Biological Effective Dose
Attalla K, Sagalovich D, Waingankar N, Mehrazin R, Stock R, Stone N, American Urological Association Annual Meeting, Boston, Massachusetts, 5/12/2017
Open Partial Nephrectomy: One Night Length of Stay Is Safe and Cost Effective
Sirohi M, Attalla K, Nagler HM, Goluboff ET, American Urological Association Annual Meeting, New Orleans, Louisiana, 5/18/2015
Robotic Partial Nephrectomy in Renal Units with Multiple Renal Arteries
Attalla K, Rizkala ER, Autorino R, Khalifeh A, Samarasekera D, Laydner H, Haber GP, Stein RS, Kaouk JH, World Congress of Endourology, New Orleans, Louisiana, 10/24/2014
Oxalate Content of Food: a Tangled Web
Attalla K, De S, Monga M, American Urological Association Annual Meeting, Orlando, Florida, 5/20/2014
Seasonal Variations in Urinary Calcium
Attalla K, De S, Sarkissian C, Monga M, American Urological Association Annual Meeting, Orlando, Florida, 5/18/2014
Join now to see all

Authored Content

The Evolution of Bladder Cancer Genomics: What Have We Learned and How Can We Use It?March 2018

Press Mentions

Robotic vs. Open Radical Cystectomy for Bladder CancerJuly 10th, 2017
Robotic, Open Radical Cystectomy Offer Similar ResultsJuly 10th, 2017
ASCO GU 2020: The Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell CarcinomaFebruary 19th, 2020
Join now to see all